COVID-19 Clinical Trial
Official title:
Dime La VerDAD: Verify, Debunk, and Disseminate
Dime La VerDAD is an innovative social media capacity-building program that empowers promotores de salud to debunk vaccine misinformation through the use of personal narratives on social media. The core of the implementation strategy consists of augmenting training and self-efficacy for natural community champions, "promotores de salud" from the Hispanic community as trusted messengers to debunk vaccination misinformation. Our study will leverage existing community relationships in Chicago and a first of its kind misinformation curriculum to debunk misinformation in communities served by participating promotores de salud. Dime La VerDAD (Verify, Debunk, and Disseminate) is an innovative social media capacity-building program based on theoretical frameworks related to health communication that empowers promotores de salud to debunk vaccine misinformation through the use of personal narratives on social media. This mixed methods study will use a rigorous stepped wedge design to 1) deliver a scalable program of science communicators using an adapted curriculum grounded in infodemiology, 2) evaluate how debunking misinformation is perceived on social media, and 3) discern how use of personal narratives to enhance science communication can lead to changes in opinions and behavior (vaccination rates) about COVID and influenza vaccines among Chicago's predominantly Hispanic communities.
Status | Recruiting |
Enrollment | 1400 |
Est. completion date | April 1, 2028 |
Est. primary completion date | June 30, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - Inclusion criteria: 18 years or older; fluent in English or Spanish; provide services in at least one of the priority zip codes 60639, 60651, 60623, 60608, 60629, 60632 selected as priority areas in the Protect Chicago Plus program instituted in response to the COVID19 pandemic (see Johnson AK, Smith CS, Hunt B, Jacobs J, Roesch P. Chicago's Citywide COVID-19 Vaccine Equity Program: Protect Chicago Plus. Public Health Rep. 2023;138(2):218-222. doi:10.1177/00333549221143093); have a social media presence (personal or work-related) Exclusion Criteria: - Exclusion: Plans to stop working as a "promotor" before spring of 2027 (end of data collection planned). You can not participate if you are under the age of 18, or can not understand Spanish and English, or do not provide services in the included zip codes, or do not wish to participate in social media. |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
United States | Rush University | Chicago | Illinois |
United States | University of Chicago | Chicago | Illinois |
United States | University of Iowa | Iowa City | Iowa |
Lead Sponsor | Collaborator |
---|---|
Marina Del Rios | Bedford Research Corporation, Inc., National Institute on Minority Health and Health Disparities (NIMHD), Rush University Medical Center, Tanoma Consulting, University of Chicago, University of Michigan |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vaccine uptake among promotores' social media followers | Promotores' social media followers' intent to vaccinate against COVID and/or influenza. Members of promotores' social media circles will be surveyed to understand the reach and effectiveness of various types of social media posts. We will measure effectiveness by surveying the social circles of the Promotores six months after the implementation of the curriculum (see recruitment and retention plan), and after the completion of the campaign. Specific items will include which posts the social circle members remembered most and why. We will also ask whether this changed their thinking about COVID-19 and/or influenza vaccines and or the specific call to action that was put in the infographic. | Year 2 - Year 4 | |
Primary | Promotores' Social Media Self-Efficacy | Compare promotores confidence with addressing misinformation on social media before and after completing the Dime LaVerDAD science communication curriculum. 15-minute survey to assess their work-related social media communication self-efficacy. The baseline survey will also gather demographics, social determinants of health and baseline usage of Facebook and other social media (e.g., social media apps they use, the number of friends on each social media platform, the frequency of reading from and posting/sharing on each platform), and confidence and preparedness to address misinformation in their communities regarding vaccines (COVID-19 and influenza). | Year 1 - Year 3 | |
Secondary | Learner satisfaction | Learner satisfaction will be measured through post evaluations using Likert items based on satisfaction with the course and willingness to recommend to others. | Year 2 - Year 4 | |
Secondary | Verify vaccine-related beliefs in Hispanic communities in Chicago | Obtained through focus groups of promotores de salud. An interview guide will include questions aimed at verifying their use of social media as an information source about vaccines, vaccine-related misbeliefs, characteristics of information sources they trust, perceptions of vaccine safety, and personal plans to get vaccinated. Questions will be developed based on the Appreciative Inquiry (AI) model which is an asset-based approach to organizational and social engagement that utilizes questions and dialogue to help participants uncover existing strengths, advantages, or opportunities in their communities, organizations, or teams | Year 1-2 | |
Secondary | Social media engagement | We will first use social media data analytics to measure and understand reach in cyberspace. We will ask for each promotor/a's consent and train them how to export their Facebook posts into JSON files that will be shared with the research team. If we need to add another emerging social media platform that does not support direct data export, we will explore different options to retrieve data, such as joining promotores' social circles or group chats, or instruct promotores to self-report data of their social media posts. We will quantify the volume of "impressions" (i.e., the number of users who will see the post) and "buzz" generated by promotores (e.g., numbers of likes, comments or shares). Then text analytics methods will be adopted to analyze more fine-grained reactions to these posts. | Years 1- 5 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|